Skip to main content
Bioten Co., Ltd logo

Bioten Co., Ltd — Investor Relations & Filings

Ticker · 289170 ISIN · KR7289170003 KO Manufacturing
Open in API
Filings indexed 40 across all filing types
Latest filing 2025-03-11 Proxy Solicitation & In…
Country KR South Korea
Listing KO 289170

About Bioten Co., Ltd

http://biotencosmetics.com/

Bioten Co., Ltd. is a biotechnology company specializing in the development, manufacturing, and sale of products derived from natural materials. The company's portfolio includes health functional foods, supplementary food products, animal feed additives, and functional cosmetics. Key offerings are based on proprietary materials and include curcumin-based products, such as Tencumin S Plus, as well as probiotics and collagen supplements. These products are designed to support functions including immunity, liver health, and blood sugar management. The company utilizes its own patented equipment and natural solvents in its development and production processes.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) issued by Biothen. It details the date, location, and agenda items (financial statement approval, director/auditor appointments, and compensation limits). This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon.
2025-03-11 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for the 14th Annual General Meeting of Bioten Co., Ltd. It includes the meeting agenda, voting procedures, and detailed financial statements (balance sheet, income statement, cash flow statement) as part of the management's reporting for the fiscal year. This document is a standard proxy statement/notice package provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-03-11 Korean
주요사항보고서(유형자산양도결정)
M&A Activity Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Services Commission and Korea Exchange regarding the decision to dispose of tangible assets (real estate). This type of regulatory filing, which details specific corporate events like asset sales, falls under the 'Regulatory Filings' category as it is a mandatory disclosure of a material event that does not fit into more specific categories like M&A or share issuance.
2025-02-18 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the upcoming 14th Annual General Meeting. It does not contain the full report or proxy materials themselves, but rather serves as a formal notice of a corporate action (setting a record date). Given the nature of the announcement and the lack of a specific category for 'Record Date Notice', it falls under the general regulatory filing category.
2024-12-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Financial Investment Services and Capital Markets Act. This document reports changes in share ownership (specifically, conversion of convertible bonds into common stock) by Fine Value Asset Management regarding BioTen Co., Ltd. This falls under the category of Major Shareholding Notification.
2024-11-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the change in shareholding (specifically the conversion of preferred shares to common shares) by a major shareholder, '파인밸류자산운용(주)' (Fine Value Asset Management), in the company '바이오텐 주식회사' (Bioten Co., Ltd.). This type of filing is a standard regulatory disclosure for major shareholding changes and insider ownership reporting, which falls under the 'Major Shareholding Notification' category.
2024-11-19 Korean

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.